| Structural highlights
1eb2 is a 1 chain structure with sequence from Bos taurus. Full crystallographic information is available from OCA. For a guided tour on the structure components use FirstGlance.
| | Ligands: | , , |
| Related: | 1aq7, 1auj, 1az8, 1bju, 1bjv, 1btp, 1btw, 1btx, 1bty, 1btz, 1c1n, 1c1o, 1c1p, 1c1q, 1c1r, 1c1s, 1c1t, 1c2d, 1c2e, 1c2f, 1c2g, 1c2h, 1c2i, 1c2j, 1c2k, 1c2l, 1c2m, 1c5p, 1c5q, 1c5r, 1c5s, 1c5t, 1c5u, 1c5v, 1c9t, 1ce5, 1cu7, 1cu8, 1cu9, 1d6r, 1ejm, 1ezx, 1f0t, 1f0u, 1f2s, 1g3b, 1g3c, 1g3d, 1g3e, 1g9i, 1gbt, 1hj9, 1jrs, 1jrt, 1max, 1may, 1mts, 1mtu, 1mtv, 1mtw, 1ntp, 1ppc, 1ppe, 1pph, 1qa0, 1qb1, 1qb6, 1qb9, 1qbn, 1qbo, 1qcp, 1ql7, 1ql8, 1sbw, 1sfi, 1smf, 1tab, 1taw, 1tgb, 1tgc, 1tgn, 1tgs, 1tgt, 1tio, 1tld, 1tng, 1tnh, 1tni, 1tnj, 1tnk, 1tnl, 1tpa, 1tpo, 1tpp, 1tps, 1tyn, 1xuf, 1xug, 1xuh, 1xui, 1xuj, 1xuk, 1yyy, 1zzz, 2btc, 2bza, 2ptc, 2ptn, 2tga, 2tgd, 2tgp, 2tgt, 2tio, 2tld, 2tpi, 3btd, 3bte, 3btf, 3btg, 3bth, 3btk, 3btm, 3btq, 3btt, 3btw, 3ptb, 3ptn, 3tgj, 3tpi, 4tpi, 5ptp |
| Activity: | Trypsin, with EC number 3.4.21.4 |
| Resources: | FirstGlance, OCA, PDBe, RCSB, PDBsum, ProSAT |
Evolutionary Conservation
Check, as determined by ConSurfDB. You may read the explanation of the method and the full data available from ConSurf.
Publication Abstract from PubMed
In silico screening of combinatorial libraries prior to synthesis promises to be a valuable aid to lead discovery. PRO_SELECT, a tool for the virtual screening of libraries for fit to a protein active site, has been used to find novel leads against the serine protease factor Xa. A small seed template was built upon using three iterations of library design, virtual screening, synthesis, and biological testing. Highly potent molecules with selectivity for factor Xa over other serine proteases were rapidly obtained.
PRO_SELECT: combining structure-based drug design and array-based chemistry for rapid lead discovery. 2. The development of a series of highly potent and selective factor Xa inhibitors.,Liebeschuetz JW, Jones SD, Morgan PJ, Murray CW, Rimmer AD, Roscoe JM, Waszkowycz B, Welsh PM, Wylie WA, Young SC, Martin H, Mahler J, Brady L, Wilkinson K J Med Chem. 2002 Mar 14;45(6):1221-32. PMID:11881991[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
See Also
References
- ↑ Liebeschuetz JW, Jones SD, Morgan PJ, Murray CW, Rimmer AD, Roscoe JM, Waszkowycz B, Welsh PM, Wylie WA, Young SC, Martin H, Mahler J, Brady L, Wilkinson K. PRO_SELECT: combining structure-based drug design and array-based chemistry for rapid lead discovery. 2. The development of a series of highly potent and selective factor Xa inhibitors. J Med Chem. 2002 Mar 14;45(6):1221-32. PMID:11881991
|
